THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CANCER OF THE PROSTATE RISK ASSESSMENT SCORE: A STRAIGHTFORWARD AND RELIABLE PREOPERATIVE PREDICTOR OF DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMY-Reference-Cited by-同舟云学术

THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CANCER OF THE PROSTATE RISK ASSESSMENT SCORE: A STRAIGHTFORWARD AND RELIABLE PREOPERATIVE PREDICTOR OF DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMY

Published:2005-06 Issue:6 Volume:173 Page:1938-1942
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

COOPERBERG MATTHEW R.¹,PASTA DAVID J.¹,ELKIN ERIC P.¹,LITWIN MARK S.¹,LATINI DAVID M.¹,Du CHANE JANEEN¹,CARROLL PETER R.¹

Affiliation:

1. University of California, San Francisco, San Francisco, and University of California, Los Angeles, Los Angeles, California (MSL), and TAP Pharmaceutical Products, Inc., Lake Forest, Illinois (JD)

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Cancer Statistics, 2004

2. Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer

3. A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer

4. Comprehensive Comparison of Health-Related Quality of Life After Contemporary Therapies for Localized Prostate Cancer

5. A CATALOG OF PROSTATE CANCER NOMOGRAMS

Cited by 617 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI characteristics predict risk of pathological upgrade in patients with ISUP grade group 1 prostate cancer;European Radiology;2024-09-13

2. Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing;Prostate Cancer and Prostatic Diseases;2024-09-05

3. Multiplex imaging of localized prostate tumors reveals altered spatial organization of AR-positive cells in the microenvironment;iScience;2024-09

4. Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world Setting;European Urology Oncology;2024-08

5. Clinical Tools for Optimizing Therapeutic Decision-Making in Prostate Cancer: A Five-Year Retrospective Analysis;Life;2024-06-30